Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study.

Nishiguchi S, Enomoto H, Aizawa N, Nishikawa H, Osaki Y, Tsuda Y, Higuchi K, Okazaki K, Seki T, Kim SR, Hongo Y, Jyomura H, Nishida N, Kudo M

Open source

DOI
10.1007/s00535-013-0785-2
Published
2014 Mar
Container
Journal of gastroenterology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00535-013-0785-2,
  title = {Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study.},
  author = {Nishiguchi S and Enomoto H and Aizawa N and Nishikawa H and Osaki Y and Tsuda Y and Higuchi K and Okazaki K and Seki T and Kim SR and Hongo Y and Jyomura H and Nishida N and Kudo M},
  year = {2014},
  journal = {Journal of gastroenterology},
  doi = {10.1007/s00535-013-0785-2},
  url = {https://doi.org/10.1007/s00535-013-0785-2}
}

RIS

TY  - JOUR
TI  - Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study.
AU  - Nishiguchi S
AU  - Enomoto H
AU  - Aizawa N
AU  - Nishikawa H
AU  - Osaki Y
AU  - Tsuda Y
AU  - Higuchi K
AU  - Okazaki K
AU  - Seki T
AU  - Kim SR
AU  - Hongo Y
AU  - Jyomura H
AU  - Nishida N
AU  - Kudo M
PY  - 2014
JO  - Journal of gastroenterology
DO  - 10.1007/s00535-013-0785-2
UR  - https://doi.org/10.1007/s00535-013-0785-2
ER  - 

APA

S, N., H, E., N, A., H, N., Y, O., Y, T., K, H., K, O., T, S., SR, K., Y, H., H, J., N, N., & M, K. (2014). Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study.. Journal of gastroenterology. https://doi.org/10.1007/s00535-013-0785-2

Source records